B-cell Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for B-cell Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-05-21Clinical Trial Update: Azacytidine, Bendamustine, Piamprizumab in Refractory/Relapsed B-cell Non-Hodgkin's Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial investigating azacytidine, bendamustine, and piamprizumab in refractory/relapsed B-cell non-Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2021-03-03Clinical Trial Update: Clinical Trial in Chinese Patients of B-cell Non-Hodgkin's Lymphoma(GB226) [Phase 2]
A Phase 2 clinical trial update for GB226 in Chinese patients with B-cell non-Hodgkin's lymphoma is reported; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2021-01-13Clinical Trial Update: Study to Evaluate Safety and Efficacy of Blinatumomab in Subjects With Relapsed/Refractory (R/R) Aggressive B-Cell NHL [Phase 2, Phase 3]
Phase 2/3 clinical trial update for blinatumomab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma completed with posted results…
-
CLINICAL_TRIALS trial_result · 2021-01-07Clinical Trial Update: A Phase 2 Clinical Trial of Rituxan and B-Glucan PGG in Relapsed Indolent Non-Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating Rituxan (rituximab) with beta-glucan PGG in relapsed indolent B-cell non-Hodgkin lymphoma has completed, with resul…
-
CLINICAL_TRIALS trial_result · 2020-11-27Clinical Trial Update: Open-Label Extension Study of De-immunized DI-Leu16-IL2 Immunocytokine Administered in Participants With B-cell NHL [Phase 1, Phase 2]
Open-label extension study of de-immunized DI-Leu16-IL2 immunocytokine in participants with B-cell non-Hodgkin lymphoma; study terminated wi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-11-24Clinical Trial Update: A Study of De-immunized DI-Leu16-IL2 Administered Subcutaneously in Participants With B-cell NHL [Phase 1, Phase 2]
Phase 1/2 trial of de-immunized DI-Leu16-IL2 for B-cell non-Hodgkin lymphoma; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-23Clinical Trial Update: Anti-CD20 Radioimmunotherapy Before Chemotherapy and Stem Cell Transplant in Treating Patients With High-Risk B-Cell Malignancies [Phase 1]
Phase 1 trial evaluating anti-CD20 radioimmunotherapy before chemotherapy and stem cell transplant in high-risk B-cell malignancies; trial s…
-
CLINICAL_TRIALS trial_result · 2020-10-05Clinical Trial Update: An Investigational Immuno-therapy Study to Determine the Safety of Urelumab Given in Combination With Nivolumab in Solid Tumors and B-cell Non-Hodgkin's Lymphoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating urelumab with nivolumab in advanced solid tumors and advanced B-cell non-Hodgkin's lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: Chemotherapy and Monoclonal Antibody Therapy in Treating Patients With B-cell Non-Hodgkin's Lymphoma That Has Relapsed Following Peripheral Stem Cell Transplantation [Phase 2]
Phase 2 clinical trial evaluating chemotherapy and monoclonal antibody therapy in patients with B-cell non-Hodgkin's lymphoma relapsed after…
-
CLINICAL_TRIALS trial_result · 2020-03-03Clinical Trial Update: A Study of Polatuzumab Vedotin in Combination With Rituximab or Obinutuzumab, Cyclophosphamide, Doxorubicin, and Prednisone in Participants With B-Cell Non-Hodgkin's Lymphoma [Phase 1, Phase 2]
Clinical trial update on polatuzumab vedotin in combination with standard chemoimmunotherapy in B-cell non-Hodgkin's lymphoma (Phase 1/2) co…
-
CLINICAL_TRIALS trial_result · 2019-10-21Clinical Trial Update: Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia [Phase 2]
Phase 2 clinical trial assessing management of platelet transfusion therapy in patients with blood cancers or treatment-induced thrombocytop…
-
CLINICAL_TRIALS trial_result · 2019-01-28Clinical Trial Update: Alisertib and Romidepsin in Treating Patients With Relapsed or Refractory B-Cell or T-Cell Lymphomas [Phase 1]
Phase 1 study of alisertib plus romidepsin in relapsed or refractory B-cell and T-cell lymphomas has completed.
-
CLINICAL_TRIALS trial_result · 2018-10-26Clinical Trial Update: Study Evaluating CMC-544 In B-Cell Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial evaluating CMC-544 in B-cell non-Hodgkin's lymphoma has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-09-04Clinical Trial Update: Radiolabeled Monoclonal Antibody and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With High-Risk Lymphoid Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating a radiolabeled monoclonal antibody with combination chemotherapy before stem cell transplant in high-ris…
-
CLINICAL_TRIALS trial_result · 2018-07-06Clinical Trial Update: Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BEAM Followed By ASCT For Relapsed B-Cell Non-Hodgkin Lymphoma [Phase 2]
Phase 2 study evaluating Yttrium-90 ibritumomab tiuxetan added to high-dose BEAM chemotherapy followed by autologous stem cell transplant in…
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: CPI-613, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial evaluating a triple regimen of devimistat (CPI-613), bendamustine hydrochloride, and rituximab in relapsed or refractory B-cel…
-
CLINICAL_TRIALS trial_result · 2018-04-11Clinical Trial Update: Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma [Phase 1]
Phase 1 study evaluating alisertib in combination with vorinostat in adults with relapsed or recurrent Hodgkin lymphoma, B-cell non-Hodgkin …
-
CLINICAL_TRIALS trial_result · 2018-04-11Clinical Trial Update: Ipilimumab and Rituximab in Treating Patients With Relapsed or Refractory B-cell Lymphoma [Phase 1]
This document reports the completion of a Phase 1 study evaluating the combination of ipilimumab and rituximab in relapsed or refractory CD2…
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: Study of Safety and Efficacy of C-CAR011 in B-NHL Patients [Phase 1]
A Phase 1 study is evaluating the safety and efficacy of C-CAR011 in patients with refractory or relapsed B-cell non-Hodgkin lymphoma. The c…
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating bortezomib plus vorinostat as maintenance after autologous stem cell transplant in non-Hodgkin lymphoma showed resu…
-
CLINICAL_TRIALS trial_result · 2017-04-19Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of Urelumab (BMS-663513) in Subjects With Advanced and/or Metastatic Solid Tumors and Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial evaluating Urelumab (BMS-663513) in patients with advanced/metastatic solid tumors and relapsed/refractory B-cell non-Hodgkin'…
-
CLINICAL_TRIALS research · 2017-04-11Clinical Trial Update: Chidamide Plus DICE Regimen for Patients With Relapse or Refractory B-cell Non-Hodgkin's Lymphoma (NHL) [Phase 2]
This document describes an ongoing Phase 2 clinical trial evaluating chidamide in combination with the DICE regimen for relapsed or refracto…
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: Combination Study of Urelumab and Rituximab in Patients With B-cell Non-Hodgkins Lymphoma [Phase 1]
Phase 1 study updating on the combination of urelumab and rituximab in patients with B-cell non-Hodgkin lymphoma, which has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-06Clinical Trial Update: Veltuzumab and Milatuzumab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating veltuzumab and milatuzumab for relapsed or refractory B-cell non-Hodgkin lymphoma; results were poste…
-
CLINICAL_TRIALS trial_result · 2016-12-14Clinical Trial Update: Retrospective Analysis on Relapsed/Refractory Aggressive Non Hodgkin Lymphoma Treated With Z-BEAM Plus ASCT
A retrospective analysis of patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma treated with Z-BEAM conditioning follow…